Cardiac events and cardiac T2* in Egyptian children and young adults with beta-thalassemia major taking deferoxamine.

Abstract

BACKGROUND AND OBJECTIVES Cardiac events and death are not uncommon in adults with beta-thalassemia (b-TM) taking deferoxamine (DFO) monotherapy because of poor compliance and possibly the less effectiveness of DFO in controlling cardiac iron overload. We sought to assess compliance with DFO, the percentage of shift to other iron chelators, and the… (More)

Topics

Cite this paper

@article{Elalfy2010CardiacEA, title={Cardiac events and cardiac T2* in Egyptian children and young adults with beta-thalassemia major taking deferoxamine.}, author={Mohsen Saleh Elalfy and Iman A Abdin and Usama Roshdy El Safy and Ahmed Sayed Ibrahim and Fatma S. E. Ebeid and Doria S Salem}, journal={Hematology/oncology and stem cell therapy}, year={2010}, volume={3 4}, pages={174-8} }